CX3CL1/CX3CR1 axis in liver disease: context-dependent roles and balance.
This review provides a systematic and critical examination of the multifaceted roles of the CX3CL1/CX3CR1 axis in liver diseases.
APA
Liu J, Guo Z, Zheng X (2026). CX3CL1/CX3CR1 axis in liver disease: context-dependent roles and balance.. Frontiers in immunology, 17, 1763348. https://doi.org/10.3389/fimmu.2026.1763348
MLA
Liu J, et al.. "CX3CL1/CX3CR1 axis in liver disease: context-dependent roles and balance.." Frontiers in immunology, vol. 17, 2026, pp. 1763348.
PMID
41716421
Abstract
This review provides a systematic and critical examination of the multifaceted roles of the CX3CL1/CX3CR1 axis in liver diseases. We emphasize its context-dependent duality-exhibiting both pro- and anti-inflammatory, pro- and anti-fibrotic, and pro- and anti-tumor functions across different etiologies. Moving beyond a binary good or bad" paradigm, we propose a contextual signaling model that integrates cellular source, microenvironmental cues, and intersecting pathways to explain its divergent roles. We synthesize recent advances in its involvement in NAFLD/NASH, viral hepatitis, autoimmune hepatitis, schistosomiasis, liver fibrosis and hepatocellular carcinoma. The review critically evaluates the axis's potential as a biomarker, discusses methodological advances and limitations in human studies, and analyzes therapeutic strategies with a focus on translational challenges. We conclude with a forward-looking perspective on precision medicine approaches targeting this axis.
MeSH Terms
Humans; Chemokine CX3CL1; CX3C Chemokine Receptor 1; Liver Diseases; Animals; Signal Transduction; Biomarkers
같은 제1저자의 인용 많은 논문 (5)
- A graded approach in East Asian personalized lower blepharoplasty: A retrospective study spanning 12 years.
- Review of complications in double eyelid surgery.
- Spatial transcriptomics and single-cell analyses reveal the role of the cisplatin-resistant gene panel in NSCLC progression and the tumor microenvironment, identifying LOXL2 as a potential therapeutic target.
- Association between C-reactive protein-to-albumin ratio and the risk of overall survival in advanced non-small cell lung cancer patients with anlotinib treatment: a retrospective cohort study.
- Early Post-discharge Pain Trajectories After Thoracoscopic Sublobar Resection for Stage IA Non-small Cell Lung Cancer.